Literature DB >> 18366953

The increasingly complex world of cancer patient advocacy organizations.

Maurie Markman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18366953     DOI： 10.1007/s11912-008-0001-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  2 in total

1.  Peer mentoring and survivors' stories for cancer patients: positive effects and some cautionary notes.

Authors:  Christine Rini; Catalina Lawsin; Jane Austin; Katherine DuHamel; Yeraz Markarian; Jack Burkhalter; Larissa Labay; William H Redd
Journal:  J Clin Oncol       Date:  2007-01-01       Impact factor: 44.544

2.  Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.

Authors:  Thomas D Denberg; Trisha V Melhado; John F Steiner
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860
  2 in total
  3 in total

1.  Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices.

Authors:  Sheila M Rothman; Victoria H Raveis; Anne Friedman; David J Rothman
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

2.  Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness.

Authors:  Susannah L Rose
Journal:  J Law Med Ethics       Date:  2013       Impact factor: 1.718

3.  Sources of health information among U.S. cancer survivors: results from the health information national trends survey (HINTS).

Authors:  Inimfon Jackson; Ikponmwosa Osaghae; Nnenna Ananaba; Aniekeme Etuk; Nsikak Jackson; Onyema G Chido-Amajuoyi
Journal:  AIMS Public Health       Date:  2020-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.